Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Defining a Personalized Hypoxic Radiation Target Through Correlation of Functional F18-FAZA PET Imaging to Pimonidazole-stained 3D Whole-mounted Histological Specimen

Next Previous
Trial Profile

Defining a Personalized Hypoxic Radiation Target Through Correlation of Functional F18-FAZA PET Imaging to Pimonidazole-stained 3D Whole-mounted Histological Specimen

Status: Suspended
Phase of Trial: Phase I/II

Latest Information Update: 14 Aug 2024

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Pimonidazole (Primary)
  • Indications Squamous cell cancer; Tongue cancer
  • Focus Diagnostic use
  • Acronyms FAITH

Most Recent Events

  • 12 Aug 2024 Planned End Date changed from 30 Jun 2024 to 1 Dec 2024.
  • 12 Aug 2024 Planned primary completion date changed from 30 Dec 2023 to 1 Sep 2024.
  • 12 Aug 2024 Status changed from recruiting to suspended ( Pause to enrolment due to COVID-19 pandemic and protocol amendment (change to equipment used)).

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top